Pharma BD Deal Intelligence
Roche Holding AG / GenMark Diagnostics
2021 · Acquisition/Merger · $1.8B · Complete
Announcement Sentiment
70
Positive
Outcome Score
61
Largely worked — most objectives met.
Roche acquired GenMark Diagnostics for $1.8B for multiplex molecular diagnostics.
Key facts
- Announced Mar 15, 2021
- Closed Apr 22, 2021
- Deal value $1.8B
- Deal type Acquisition/Merger
- Key assets Non-pharma deal
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals